Clinical Trial Update: Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial studying saroglitazar magnesium for Primary Biliary Cholangitis patients who have incomplete response or intolerance to UDCA therapy; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Saroglitazar Magnesium (saroglitazar magnesium)

Snippet

Sponsor: Zydus Therapeutics Inc. | Conditions: Primary Biliary Cholangitis | Phase 3 | Status: NOT_YET_RECRUITING